GlobeNewswire by notified

Landsbankinn hf.: Financial results of Landsbankinn for the first three months of 2024

Share
  • Landsbankinn's net profit in the first three months of 2024 was ISK 7.2 billion.
  • Return on equity (ROE) in the period was 9.3%, compared with 11.1% for the same period the previous year.
  • The net interest margin was 2.9%. The net interest margin of domestic households was 2% and remains stable.
  • Net interest income amounted to ISK 14.4 billion and net fee and commission income was ISK 2.7 billion.
  • Net impairments were negative by ISK 2.7 billion and include an ISK 2.0 billion collective allowance against uncertainty related to natural disaster on the Reykjanes peninsula.
  • The cost/income ratio was 33.6%, compared with 33.3% in the first quarter of 2023.
  • The total capital ratio was 24.9% at the end of the period. The total capital requirement of the Financial Supervisory Authority of the Central Bank of Iceland is 20.7%.
  • In March, Landsbankinn finalised the sale of green bonds in the amount of EUR 300 million, with subscriptions coming in at more than six times the size of the issuance.
  • Also in March, the Bank issued two Tier 2 bonds, one non-indexed series in the amount of ISK 3 billion and one inflation-linked series in the amount of ISK 12 billion.
  • The Bank’s AGM, held on 19 April 2024, agreed to pay a dividend to shareholders in the amount of ISK 16.5 billion, or ISK 0.70 per share, for the operating year 2023. The dividend is equivalent to around 50% of the Group’s 2023 profit. As a result, total dividend paid by Landsbankinn in 2013-2024 will amount to ISK 191.7 billion.
  • In January, for the fifth year in a row, customers in the banking market are most satisfied with Landsbankinn’s services, according to the Icelandic Performance Satisfaction Index 2023.
  • In early April, S&P Global Ratings upgraded the Bank’s credit rating to BBB+/A-2 with stable outlook.

Lilja Björk Einarsdóttir, CEO of Landsbankinn:

“It is quite a milestone that Landsbankinn’s balance sheet has now exceeded ISK 2,000 billion, doubling in size from its initial balance sheet in 2008. The balance sheet has grown surely and steadily, and in the first quarter of this year, the increase amounts to just under ISK 72 billion. A growing balance sheet enables us to provide even better support for Icelandic industry and society. Strong lending activity is a core function of the Bank’s operation. There has been moderate growth in housing mortgages and more refinancing activity. Corporate lending grew steadily to reach an increase of ISK 30 billion in the quarter.

The Bank’s funding was exceptionally successful in the quarter. We issued subordinated bonds in the amount of ISK 15 billion and EUR 300 million green bonds at favourable terms. In April, we received the enjoyable news that international rating firm S&P Global Ratings had raised the Bank’s credit rating a notch.

Profitability has dwindled slightly but remains close to our long-term target. The main reason for lower profitability is the increased allowance the Bank made in the quarter against seismic and volcanic activity in the Grindavík area. It is important that the Bank has the financial strength to respond to the effect of this natural disaster and that it continues to be able to support its Grindavík customers. We expect profitability to grow again as the year progresses and to hover above the Bank’s target. It is worth noting that the recently raised reserve requirement of the Central Bank of Iceland (CBI) means that Landsbankinn will sit with ISK 40 billion on a non-interest-bearing account with the CBI, a 20% increase from the previous requirement. The cost increase for the Bank comes to ISK 1 billion per year.

The Bank’s results reflect solid and robust operations. We continue to develop exciting and efficient new solutions for customers. Among new solutions in the first quarter is the option to refinance housing mortgages through self-service in Landsbankinn’s app. This has never been possible before in Iceland and the solution is innovative even by international standards. It will certainly simplify life for customers. We introduced our chatbot Ellí in the quarter with immediate success - she currently finalises around half of all customer queries in the web chat on landsbankinn.is. Customers have been very happy with the chatbot service. It has also been gratifying to see that customers regularly use the chat function to leave reviews of the Bank’s service and their interaction with employees. By continuing to develop new solutions, we provide even better service to Landsbankinn’s customers, who are the most satisfied in the banking market.”

Landsbankinn's financial calendar

  • Q2 2024 results 18 July 2024
  • Q3 2024 results 23 October 2024
  • Annual results 2024 30 January 2025 

For further information contact:

Public Relations, pr@landsbankinn.is

Investor Relations, ir@landsbankinn.is

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Constellation Brands to Present at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 202416.5.2024 22:30:20 CEST | Press release

VICTOR, N.Y., May 16, 2024 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that Bill Newlands, President and Chief Executive Officer, and Garth Hankinson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 2024 in New York, NY. The presentation is scheduled to begin at 2:30 p.m. EDT and is expected to cover the company’s strategic business initiatives, financial metrics, and operating performance, as well as outlook for the future. A live, listen-only webcast of the presentation will be available on the company’s investor relations website at ir.cbrands.com under the News & Events section. When the presentation begins, financial information discussed in the presentation, and a reconciliation of reported GAAP financial measures with comparable and other non-GAAP financial measures, will also be available

DBV Technologies Announces Results of its 2024 Combined General Meeting16.5.2024 22:30:00 CEST | Press release

Châtillon, France, May 16, 2024 DBV Technologies Announces Results of its 2024 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, held its Combined General Meeting (the “General Meeting”). The General Meeting was chaired by Michel de Rosen, Chairman of the Company. The Company’s shareholders approved all resolutions submitted by the Board of Directors. These resolutions and their results are posted on the Investors/Annual General Meetings section of the Company’s website: https://dbv-technologies.com/events/2024-annual-general-meeting/. About DBV Technologies DBV Technologies is a clinical-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with sign

Clean Motion AB delårsredogörelse för januari-mars 202416.5.2024 22:10:00 CEST | Pressemelding

Elfordonstillverkaren Clean Motion AB presenterar sin delårsrapport för januari-mars 2024. Bolaget redovisar en försäljning på 38 (45) TSEK och ett rörelseresultat exklusive avskrivningar (EBITDA) på -2 949 (-1 825) TSEK. Bolaget meddelar även att ett licensavtal är tecknat för tillverkning av Zbee i Indien samt att deras nya produktionslokal för EVIG i Jonsered nu är godkänd. Sofia Haby, VD kommenterar; ”Vi har jobbat intensivt under kvartalet med både typgodkännande-processen och flytt till nya lokaler. Kvartalet har präglats av de förseningar som vi drabbats av med vårt typgodkännande, vilket förhindrat försäljning i Europa. Jag kan nu med glädje meddela att det mest kritiska testet blev godkänt igår kväll! Under de senaste månaderna har vi jobbat med att färdigställa vår nya produktionslokal i Jonsered. Jag är övertygad om att vi genom att samla alla resurser under ett tak, kommer att åstadkomma stora effektivitetsförbättringar. Teamet har arbetat dedikerat med att säkerställa en s

Galapagos creates new subscription right plans16.5.2024 22:01:00 CEST | Press release

Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries. On 16 May 2024, the Board of Directors of Galapagos approved “Subscription Right Plan 2024 BE”, intended for members of personnel of the company, “Subscription Right Plan 2024 RMV,” intended for the employees of its French subsidiary, Galapagos SASU, and “Subscription Right Plan 2024 ROW”, primarily intended for the employees of its other non-Belgian subsidiaries, within the framework of the authorized capital. Under these subscription right plans, 1,614,000 subscription rights were created, subject to acceptances, and offered to the beneficiaries of the plans. The subscription rights have an exercise term of eight years as of the date of the offer and have an exercise price of €

Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH16.5.2024 22:00:00 CEST | Press release

The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.The recommendation was based on the unblinded review by the DMC of safety data from more than 900 patients randomized in the main and exploratory cohorts, including more than 360 and 80 patients that have been treated for more than 48 and 72 weeks, respectively.The patient who experienced the adverse event of increased liver test results, which was reported as a SUSAR, has been without clinical symptoms throughout the period of observation and has fully recovered.The DMC review confirms the good safety profile of lanifibranor. Daix (France), Long Island City (New York, United States), May 16, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepa

HiddenA line styled icon from Orion Icon Library.Eye